Nymox Pharma (NYMX) Reports Q3 Loss of $0.02/Share

Nymox Pharma (NASDAQ: NYMX) reported Q3 EPS of ($0.02), versus ($0.03) reported last year. Revenue for the quarter came in at $81.1 thousand, versus $88.9 thousand reported last year.

For earnings history and earnings-related data on Nymox Pharma (NYMX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
• Lument Finance Trust (LFT) Misses Q2 EPS by 17c